TY - JOUR
T1 - Clinical outcomes of image-guided percutaneous drainage of pericardial effusion in cancer patients
T2 - A single-center retrospective analysis
AU - Hasegawa, Tetsuya
AU - Arai, Yasuaki
AU - Sone, Miyuki
AU - Sugawara, Shunsuke
AU - Itou, Chihiro
AU - Wada, Shinji
AU - Umakoshi, Noriyuki
AU - Kubo, Takatoshi
AU - Kimura, Shintaro
AU - Kusumoto, Masahiko
N1 - Publisher Copyright:
© 2022 John Wiley & Sons Australia, Ltd.
PY - 2022
Y1 - 2022
N2 - Aim: Catheter removal, survival, and recurrence rates after percutaneous pericardial effusion drainage in cancer patients are not fully understood. We evaluated the clinical outcomes of image-guided percutaneous pericardial effusion drainage in cancer patients. Methods: From January 2014 to September 2017, 113 percutaneous drainages for symptomatic pericardial effusion were performed in 100 cancer patients (median 60 years; range, 7–84 years) using ultrasound or angio-computed tomography. An 8-Fr drainage catheter was placed using the Seldinger technique via the subxiphoid (n = 73), apical (n = 23), or left parasternal (n = 17) routes. Success rates, complications, and postprocedural clinical outcomes of drainages were retrospectively assessed. Results: The technical and clinical success rates were 100% and 99%, respectively, without major complications. The median duration of catheterization and evacuated pericardial effusion volume were 6 days (range, 1–72 days) and 970 ml (range, 140–7635 ml), respectively. Catheters were removed after the first drainage in 86 cases (86%). Symptomatic pericardial effusion recurred in nine patients after catheter removal, in whom redrainages were performed 13 times with a median duration to redrainage time of 48 days (range, 13–529 days). During the follow-up period (median 106 days [range, 1–1396 days]), 61 patients died. The median survival was 140 days (95% confidence interval [CI], 95–276 days), and the median catheter-free survival was 111 days (95% CI, 60–152 days). Conclusions: Image-guided percutaneous pericardial effusion drainage for cancer patients is safe and helps alleviate symptoms. Additionally, catheter removal is possible in most patients, allowing a catheter-free period for patients.
AB - Aim: Catheter removal, survival, and recurrence rates after percutaneous pericardial effusion drainage in cancer patients are not fully understood. We evaluated the clinical outcomes of image-guided percutaneous pericardial effusion drainage in cancer patients. Methods: From January 2014 to September 2017, 113 percutaneous drainages for symptomatic pericardial effusion were performed in 100 cancer patients (median 60 years; range, 7–84 years) using ultrasound or angio-computed tomography. An 8-Fr drainage catheter was placed using the Seldinger technique via the subxiphoid (n = 73), apical (n = 23), or left parasternal (n = 17) routes. Success rates, complications, and postprocedural clinical outcomes of drainages were retrospectively assessed. Results: The technical and clinical success rates were 100% and 99%, respectively, without major complications. The median duration of catheterization and evacuated pericardial effusion volume were 6 days (range, 1–72 days) and 970 ml (range, 140–7635 ml), respectively. Catheters were removed after the first drainage in 86 cases (86%). Symptomatic pericardial effusion recurred in nine patients after catheter removal, in whom redrainages were performed 13 times with a median duration to redrainage time of 48 days (range, 13–529 days). During the follow-up period (median 106 days [range, 1–1396 days]), 61 patients died. The median survival was 140 days (95% confidence interval [CI], 95–276 days), and the median catheter-free survival was 111 days (95% CI, 60–152 days). Conclusions: Image-guided percutaneous pericardial effusion drainage for cancer patients is safe and helps alleviate symptoms. Additionally, catheter removal is possible in most patients, allowing a catheter-free period for patients.
KW - cancer patients
KW - catheter-free period
KW - percutaneous drainage
KW - pericardial drainage
KW - pericardial effusion
UR - http://www.scopus.com/inward/record.url?scp=85133956670&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85133956670&partnerID=8YFLogxK
U2 - 10.1111/ajco.13810
DO - 10.1111/ajco.13810
M3 - Article
AN - SCOPUS:85133956670
JO - Asia-Pacific Journal of Clinical Oncology
JF - Asia-Pacific Journal of Clinical Oncology
SN - 1743-7555
ER -